卖什么
Neural interfaces to understand and use nerve data in medicine.
商业模式拆解
买家：谁掌握预算？
未核实R&D and clinical development leaders at pharma and bioelectronic device companies.
触发点：什么让他们现在购买？
Slow feedback on drug efficacy and dosing; BIOS claims cutting efficacy feedback from months to minutes.
工作流：什么输入变成什么输出？
Neural recording interface plus AI for biomarker discovery, patient stratification, automated stimulation settings and remote outcome metrics via wearables.
经济账：省了什么，怎么收费？
Long-term co-development partnerships on neural digital therapies; claims 15x faster discovery and optimal dose in under 10 minutes.
渠道：怎么接触到客户？
Direct partnership sales via Contact the BIOS team.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2017 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.